HUMACYTE INC. - COMMO
5.5000
07-十月-24 15:59:59
15 分钟延时
股票
+0.0600
+1.10%
今日范围
5.3700 - 5.7150
ISIN
N/A
来源
NASDAQ
-
Humacyte Expands Board of Directors and Leadership Team with New Appointments
20 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
09 9月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Humacyte Presents at Multiple Conferences in September 2022
08 9月 2022 08:01:00 条件 Nasdaq GlobeNewswire
-
Humacyte Second Quarter 2022 Financial Results and Business Update
12 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
05 8月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
25 7月 2022 20:26:26 条件 Nasdaq GlobeNewswire
-
19 7月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
07 7月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
29 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.
27 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
21 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Humacyte Presents New Immunogenicity Data on Human Acellular Vessels™ (HAVs™)
08 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte to Present at the H.C. Wainwright Global Investment Conference
16 5月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Humacyte First Quarter 2022 Financial Results and Business Update
13 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
09 5月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
06 5月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
05 4月 2022 08:00:03 条件 Nasdaq GlobeNewswire
-
Humacyte Announces Date of Annual Shareholder Meeting
04 4月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
29 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire